You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 諾泰生物(688076.SH)漲逾7% 多個長鏈修飾多肽藥物的單批次產量已超過5公斤
格隆匯 09-30 14:14
格隆匯9月30日丨諾泰生物(688076.SH)漲逾7%,報56.85元,總市值121億元。諾泰生物近日在互動平台稱,公司成功建立了基於精準控制的手性藥物技術平台,能夠快速高效的合成多種類型的複雜手性藥物分子。同時,公司擁有基於固液融合的多肽規模化生產技術平台。公司的利拉魯肽、艾博韋泰等多個長鏈修飾多肽藥物的單批次產量已超過5公斤,比伐蘆定的單批次產量已超過12.5公斤。較高的收率和單批次產量使公司從藥品質量、生產成本、法規符合性等各方面都具有較大優勢,在全球競爭中具備較強的市場競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account